Home > Financial Ratios > JUBILANT PHARMOVA

JUBILANT PHARMOVA
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for JUBILANT PHARMOVA
Please provide your vote to see the results

JUBILANT PHARMOVA Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 13.4412.3618.8622.9025.90

What is the latest Core EBITDA Margin ratio of JUBILANT PHARMOVA ?

The latest Core EBITDA Margin ratio of JUBILANT PHARMOVA is 13.44 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202413.44
Mar202312.36
Mar202218.86
Mar202122.90
Mar202025.90

How is Core EBITDA Margin of JUBILANT PHARMOVA Trending?

Years Core EBITDA Margin % Change
Mar2024 13.44
8.74
Mar2023 12.36
-34.46
Mar2022 18.86
-17.64
Mar2021 22.9
-11.58
Mar2020 25.9 -

Other Financial Ratios of JUBILANT PHARMOVA


Compare Core EBITDA Margin ratio of peers of JUBILANT PHARMOVA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JUBILANT PHARMOVA ₹14,376.0 Cr -6.8% -5.5% 60.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,430.0 Cr -3% -8.7% 4.1% Stock Analytics
DIVIS LABORATORIES ₹145,410.0 Cr -4.7% -4.5% 58.5% Stock Analytics
CIPLA ₹113,950.0 Cr -4.3% -3.2% -3.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹99,682.3 Cr -3% -12.3% 13.8% Stock Analytics
DR REDDYS LABORATORIES ₹93,261.6 Cr -3% -6.5% -12.7% Stock Analytics


JUBILANT PHARMOVA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JUBILANT PHARMOVA

-6.8%

-5.5%

60.1%

SENSEX

-3.4%

-4.4%

0.6%


You may also like the below Video Courses